Pierre Dubois, and Gosia Majewska, “Mergers and Advertising in the Pharmaceutical Industry”, TSE Working Paper, n. 22-1380, October 2022, revised June 2025.
Emmanuelle Auriol, Sara Biancini, and Rodrigo Paillacar, “Intellectual Property Rights Protection and Trade: An Empirical Analysis”, TSE Working Paper, n. 22-1354, September 2022.
Doh-Shin Jeon, Yassine Lefouili, and Leonardo Madio, “Platform Liability and Innovation”, TSE Working Paper, n. 22-1361, September 2022, revised July 2025.
Andrew Rhodes, and Jidong Zhou, “Personalized Pricing and Competition”, TSE Working Paper, n. 22-1333, May 2022, revised March 2024.
Pierre Dubois, Ashvin Gandhi, and Shoshana Vasserman, “Bargaining and International Reference Pricing in the Pharmaceutical Industry”, TSE Working Paper, n. 22-1338, April 2022.
Renato Gomes, and Andrea Mantovani, “Regulating Platform Fees under Price Parity”, TSE Working Paper, n. 22-1325, March 2022.
Renato Gomes, Jean-Marie Lozachmeur, and Lucas Maestri, “Nonlinear Pricing in Oligopoly: How Brand Preferences Shape Market Outcomes”, TSE Working Paper, n. 22-1326, March 2022.
Michele Polo, and Patrick Rey, “Unilateral Practices, Antitrust Enforcement and Commitments”, TSE Working Paper, n. 22-1316, March 2022, revised October 2024.